Duration of LDN Psoriasis Trial
David Gluck has commented by e mail that three months might not be long enough to properly evaluate the impact of LDN on Psoriasis as it is one of the most difficult conditions to treat. My limited clinical experience would confirm the cyclical nature of the condition which seems to be very sensitive to changes in the immune system. Stress or alcohol could have a marked effect and prevent the full effect of LDN from being expressed. I plan to review the trial at the three month point and if we do not have significant changes we will consider extending it. We have recruited four of the ten target patients and will give a push in the new year for the remaining six cases.





